Godavari Biorefineries Limited (GODAVARIB)

Loading page…

Godavari Biorefineries Limited (GODAVARIB) · mywealthgrid

About

Godavari Biorefineries Limited is a diversified FMCG company in the Consumer Staples sector with a market capitalization of ₹1,265.92 Cr and quarterly revenues in the ₹420–560 Cr range. The company exhibits severe earnings volatility, swinging from ₹52.41 Cr net profit in Mar 2026 to losses exceeding ₹21 Cr in Jun 2026.

Face value: ₹10

Market cap

₹1,163 Cr

P/E

—

P/B

1.5×

Dividend yield

ROE

0.4%

ROCE

7.5%

Debt / equity

0.67

OPM

6.4%

EPS (TTM)

₹0.0

Book value

₹154.0

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Operational margin collapse: OPM fell from 15.28% (Mar 2026) to -0.34% (Jun 2026) in one quarter; researcher should verify what cost factors or market conditions drove this 15.6 percentage-point swing
Extreme net profit volatility: Profit ranged from ₹52.41 Cr (Mar 2026) to -₹42.63 Cr (Sep 2025) within eight months, creating high earnings uncertainty
Current losses persist: Both Jun 2026 quarters show negative net profit, indicating the profitability of Mar 2026 has not recurred
Minimal capital returns: ROE of 0.45% indicates the company generates almost no returns on retained equity

Generated analysis · source review pending

Growth drivers

Margin recovery: OPM reached 15.28% in Mar 2026, proving the business can generate acceptable returns; researcher should identify what drove this quarter and whether conditions can repeat
Revenue scale: Quarterly revenues ₹540+ Cr provide a platform on which restoring profitability could drive earnings recovery
Cost driver resolution: OPM volatility ranges from 15.28% to -2.16%; researcher should verify whether this reflects temporary commodity pressures or structural inefficiencies that management can address

Generated analysis · source review pending

472 historical price candles were omitted because the exchange source has not been verified.

₹227.2-3.9%1Y

Quick read

rule-based

Pros

+High promoter holding of 63.3% with no pledge

Cons

−Low return on equity of -0.2% (3-yr avg)
−Thin operating margin of 6.4%
−Weak interest coverage of 1.7×

Research score

Structured signal from quality, growth, valuation and momentum.

35/100

Business quality: 17
Growth: 32
Valuation: 55

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Hindustan UnileverHINDUNILVRHINDUNILVR	₹4,31,460 Cr	₹4,31,460 Cr	₹66,374 Cr	₹15,305 Cr	23.4%	₹14,957 Cr	23.4%	22.7%	30.6%	-79
ITCITCITC	₹3,19,619 Cr	₹3,21,805 Cr	₹96,307 Cr	₹25,682 Cr	30.4%	₹19,839 Cr	23.4%	37.2%	29%	162
Nestlé IndiaNESTLEINDNESTLEIND	₹2,52,164 Cr	₹2,52,188 Cr	₹24,437 Cr	₹5,748 Cr	22.9%	₹3,811 Cr	15.1%	58.3%	76.3%	-9
Varun Beverages LimitedVBLVBL	₹1,43,858 Cr	₹1,46,366 Cr	₹24,755 Cr	₹5,659 Cr	22.7%	₹3,386 Cr	13.8%	20.9%	16.8%	79
Britannia IndustriesBRITANNIABRITANNIA	₹1,14,672 Cr	₹1,16,030 Cr	₹19,529 Cr	₹3,627 Cr	18.5%	₹2,604 Cr	13.3%	63.7%	53.5%	-9
MaricoMARICOMARICO	₹1,01,427 Cr	₹1,01,782 Cr	₹14,309 Cr	₹2,492 Cr	17.1%	₹1,888 Cr	13.3%	39.3%	43.1%	34
United Spirits LimitedUNITDSPRUNITDSPR	₹97,115 Cr	₹97,121 Cr	₹28,118 Cr	₹2,281 Cr	8.2%	₹1,884 Cr	6.6%	27.2%	21.6%	63
Tata Consumer Products LimitedTATACONSUMTATACONSUM	₹94,705 Cr	₹96,825 Cr	₹20,860 Cr	₹2,909 Cr	13.8%	₹1,635 Cr	7.6%	8.6%	7.4%	10
Godrej Consumer Products LimitedGODREJCPGODREJCP	₹85,949 Cr	₹90,085 Cr	₹16,050 Cr	₹3,257 Cr	20.8%	₹2,052 Cr	12.3%	23.9%	15.1%	12
Dabur IndiaDABURDABUR	₹66,242 Cr	₹67,305 Cr	₹13,552 Cr	₹2,525 Cr	18.6%	₹1,972 Cr	14.2%	21.4%	17.1%	-14
Radico Khaitan LimitedRADICORADICO	₹56,733 Cr	₹57,065 Cr	₹21,531 Cr	₹1,138 Cr	4.9%	₹704 Cr	2.9%	26.2%	19.9%	113
Colgate Palmolive (India) LimitedCOLPALCOLPAL	₹47,192 Cr	₹47,192 Cr	₹6,204 Cr	₹1,900 Cr	31%	₹1,348 Cr	22%	106.4%	81.6%	-188

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	1,687	1,870	1,988
COGS	1,545	1,385	1,427
Gross profit	141	485	561
	8	381	434
	134	104	127
OPM %	7.9%	5.5%	6.4%
Depreciation	60	50	54
Interest	76	72	49
	14	17	-19
Profit before tax	—	-2	5
Tax	0	22	1
Tax %	—	1,420.8%	22.8%
	12	-23	4
PAT margin %	0.7%	-1.3%	0.2%
EPS (₹)	—	-5.1	0.7
EPS adjusted (₹)	2.9	-4.6	0.7
Annual report	—	Annual report for Mar 2025	—

₹ Cr	Mar 2024	Mar 2025	Mar 2026
Equity capital	42	51	51
Reserves	459	731	737
	654	489	530
	837	684	734
Total equity & liabilities	1,992	1,955	2,052
	849	862	866
CWIP	16	22	129
Investments	0	0	0
	1,126	1,070	1,057
Total assets	1,992	1,955	2,052

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	185	6	171
	-44	-69	-163
	-151	64	-6
Net cash flow	-10	1	3
Free cash flow	—	-65	2
CFO / Operating profit %	138.7%	5.9%	134.8%

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: 6%

Return on equity

7 years: —
5 years: —
3 years: -0%
Last year: 0%

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Sugar	1,279.45	23.04	796.12	828.38	—	—
Distillery	663.65	9.47

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	8.4%	25.9%	28.2%
EBITDA margin %	7.9%	5.5%	6.4%
EBIT margin %	4.4%	2.9%	3.7%
PAT margin %	0.7%	-1.3%	0.2%
Working capital
Receivable days	41	27	21
Inventory days	190	195	198
Payable days	—	140	146
NWC days	—	82	74
Leverage
Current ratio	0.97	1.16	1.13
Debt to EBITDA	4.9	4.72	4.17
Debt to equity	1.31	0.63	0.67
Interest coverage	1.2	1	1.7
Asset turnover	0.85	0.96	0.97
Return ratios
Return on assets %	0.6%	-1.2%	0.2%
Return on capital employed %	10%	7.2%	7.5%
Return on equity %	2.5%	-3%	0.4%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	63.31%	63.31%	63.31%	63.31%	63.31%	63.31%	63.31%	63.31%
	1.28%	1.14%	0.97%	0.63%	0.6%	0.86%	0.98%	0.22%
	14.43%	14.88%	14.17%	13.98%	11.98%	11.16%	10.39%	10.02%
Government	0%	0%	0%	0%	0%	0%	0%	0%
	20.98%	20.67%	21.55%	22.08%	24.11%	24.67%	25.32%	26.45%
No. of shareholders	—	—	—	—	93,915	91,344	88,777	89,419

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 2 fund houses

Held by these funds

5.23%

of the company's equity

All mutual funds

8.9%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

2 schemes · 2 fund houses

		Shares
ELSS – Tax Saver Fund	ICICI Prudential Mutual Fund	20.32 L	47.61	0.33%	3.968%	-0
SMALL CAP FUND	Bank of India Mutual Fund	6.47 L	15.16	0.46%	1.264%	-0

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Annual Report FY2025from bse Summary

Credit ratings

Credit Rating for the Company''s Credit Facility and Fixed Deposit17 Mar 2026

Investor Presentation and earnings call

Aug 2026Transcript AI Summary PPT REC
May 2026Transcript AI Summary PPT

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results5 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

26 announcementsExport CSV

29 Sept 2026, 5:23 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

28 Sept 2026, 6:18 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

28 Sept 2026, 5:01 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

28 Sept 2026, 1:59 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

16 Sept 2026, 10:02 amCompany Update

Announcement Under Regulation 30- Patent

General PDF

5 Sept 2026, 12:42 pmCompany Update

Announcement Under Regulation 30-Patent

General PDF

5 Sept 2026, 10:51 amCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

4 Sept 2026, 6:46 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

Date	Category	Subject	Filing
29 Sept 2026, 5:23 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
28 Sept 2026, 6:18 pm	Company Update Change in Management	Announcement under Regulation 30 (LODR)-Change in Management

Loading announcements…

Ratio	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	8.4%	25.9%	28.2%
EBITDA margin %	7.9%	5.5%	6.4%
EBIT margin %	4.4%	2.9%	3.7%
PAT margin %	0.7%	-1.3%	0.2%
Working capital
Receivable days	41	27	21
Inventory days	190	195	198
Payable days	—	140	146
NWC days	—	82	74
Leverage
Current ratio	0.97	1.16	1.13
Debt to EBITDA	4.9	4.72	4.17
Debt to equity	1.31	0.63	0.67
Interest coverage	1.2	1	1.7
Asset turnover	0.85	0.96	0.97
Return ratios
Return on assets %	0.6%	-1.2%	0.2%
Return on capital employed %	10%	7.2%	7.5%
Return on equity %	2.5%	-3%	0.4%

28 deals · 30 Oct 2024 – 16 Sept 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
16 Sept 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	4,47,141	₹245.11	₹10.96 Cr
16 Sept 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	4,47,141	₹245.02	₹10.96 Cr
16 Sept 2026	JUNOMONETA FINSOL PRIVATE LIMITED	Bulk	NSE	Buy	4,40,296	₹245.09	₹10.79 Cr
16 Sept 2026	JUNOMONETA FINSOL PRIVATE LIMITED	Bulk	NSE	Sell	4,39,179	₹245.26	₹10.77 Cr
16 Sept 2026	MICROCURVES TRADING PRIVATE LIMITED	Bulk	NSE	Sell	3,15,726	₹248.98	₹7.86 Cr
16 Sept 2026	MICROCURVES TRADING PRIVATE LIMITED	Bulk	NSE	Buy	3,15,726	₹248.87	₹7.86 Cr
16 Sept 2026	SILVERLEAF CAPITAL SERVICES PRIVATE LIMITED	Bulk	NSE	Sell	3,14,772	₹247.78	₹7.80 Cr
16 Sept 2026	SILVERLEAF CAPITAL SERVICES PRIVATE LIMITED	Bulk	NSE	Buy	3,14,772	₹247.93	₹7.80 Cr
16 Sept 2026	GRT STRATEGIC VENTURES LLP	Bulk	NSE	Sell	2,63,720	₹245.72	₹6.48 Cr
16 Sept 2026	GRT STRATEGIC VENTURES LLP	Bulk	NSE	Buy	2,63,720	₹245.57	₹6.48 Cr

1–10 of 28

1 / 3

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Godavari Biorefineries Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Return on equity

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

Board meetings1

Announcements

Ratio timeline

Not in the F&O segment

Board meetings1

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Return on equity

Segment results

Bio Based Chemicals · revenue

1

1